{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:13:01Z","timestamp":1791573181545,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research and Innovation Fund for Postgraduate of Chengdu Medical College","award":["No.YCX2022-02-05"],"award-info":[{"award-number":["No.YCX2022-02-05"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.2023NSFSC0725"],"award-info":[{"award-number":["No.2023NSFSC0725"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.2022NSFSC0690"],"award-info":[{"award-number":["No.2022NSFSC0690"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Undergraduates Innovating Experimentation Project of China","award":["No. 202213705001"],"award-info":[{"award-number":["No. 202213705001"]}]},{"name":"National Undergraduates Innovating Experimentation Project of China","award":["No. 202313705009"],"award-info":[{"award-number":["No. 202313705009"]}]},{"name":"Open Fund of Development and Regeneration Key Laboratory of Sichuan Province","award":["No.SYS20-06"],"award-info":[{"award-number":["No.SYS20-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76465-z","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T08:16:44Z","timestamp":1732349804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The MAPK\/ERK signaling pathway involved in Raddeanin A induces apoptosis via the mitochondrial pathway and G2 phase arrest in multiple myeloma"],"prefix":"10.1038","volume":"14","author":[{"given":"Ming-zheng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-mei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-chuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-qi","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-zi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jiao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"issue":"9","key":"76465_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn, C. & Morgan, G. J. Evolutionary biology of high-risk multiple myeloma. Nat. Rev. Cancer. 17(9), 543\u2013556 (2017).","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"76465_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15(12), e538\u2013e548 (2014).","journal-title":"Lancet Oncol."},{"issue":"10301","key":"76465_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(21)01338-6","volume":"398","author":"SZ Usmani","year":"2021","unstructured":"Usmani, S. Z. et al. Teclistamab, a B-cell maturation antigen x CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): A multicentre, open-label, single-arm, phase 1 study. Lancet. 398(10301), 665\u2013674 (2021).","journal-title":"Lancet"},{"key":"76465_CR4","doi-asserted-by":"crossref","unstructured":"Harousseau, J. L., Dreyling, M. & Group, E. G. W. Multiple myeloma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21(Suppl 5), v155\u20137 (2010).","DOI":"10.1093\/annonc\/mdq178"},{"key":"76465_CR5","doi-asserted-by":"crossref","unstructured":"Davis, L. N. & Sherbenou, D. W. Emerging therapeutic strategies to Overcome Drug Resistance in multiple myeloma. Cancers (Basel). 13(7) (2021).","DOI":"10.3390\/cancers13071686"},{"issue":"9","key":"76465_CR6","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41375-019-0435-7","volume":"33","author":"UH Gandhi","year":"2019","unstructured":"Gandhi, U. H. et al. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 33(9), 2266\u20132275 (2019).","journal-title":"Leukemia"},{"key":"76465_CR7","doi-asserted-by":"crossref","unstructured":"Barathan, M. et al. Naturally occurring phytochemicals to target breast cancer cell signaling. Appl. Biochem. Biotechnol (2023).","DOI":"10.1007\/s12010-023-04734-0"},{"issue":"7","key":"76465_CR8","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.7150\/ijms.52206","volume":"18","author":"B Wu","year":"2021","unstructured":"Wu, B. et al. Raddeanin a inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating beta-catenin expression. Int. J. Med. Sci. 18(7), 1609\u20131617 (2021).","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"76465_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41419-018-0417-0","volume":"9","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells. Cell. Death Dis. 9(3), 376 (2018).","journal-title":"Cell. Death Dis."},{"issue":"2","key":"76465_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2017.02.079","volume":"485","author":"JN Li","year":"2017","unstructured":"Li, J. N. et al. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 485(2), 335\u2013341 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"76465_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.phymed.2014.11.008","volume":"22","author":"YY Guan","year":"2015","unstructured":"Guan, Y. Y. et al. Raddeanin A, a triterpenoid saponin isolated from Anemone Raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling. Phytomedicine. 22(1), 103\u2013110 (2015).","journal-title":"Phytomedicine"},{"key":"76465_CR12","doi-asserted-by":"publisher","first-page":"101577","DOI":"10.1016\/j.tice.2021.101577","volume":"71","author":"L Li","year":"2021","unstructured":"Li, L. et al. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation. Tissue Cell. 71, 101577 (2021).","journal-title":"Tissue Cell."},{"issue":"26","key":"76465_CR13","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3748\/wjg.v25.i26.3380","volume":"25","author":"SS Guo","year":"2019","unstructured":"Guo, S. S., Wang, Y. & Fan, Q. X. Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells. World J. Gastroenterol. 25(26), 3380\u20133391 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"76465_CR14","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00210-023-02447-z","volume":"396","author":"Y Xing","year":"2023","unstructured":"Xing, Y. et al. Raddeanin A promotes autophagy-induced apoptosis by inactivating PI3K\/AKT\/mTOR pathway in lung adenocarcinoma cells. Naunyn Schmiedebergs Arch. Pharmacol. 396(9), 1987\u20131997 (2023).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"76465_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"76465_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"76465_CR17","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013d592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"76465_CR18","doi-asserted-by":"publisher","first-page":"e83922","DOI":"10.1371\/journal.pone.0083922","volume":"8","author":"KY Hsin","year":"2013","unstructured":"Hsin, K. Y., Ghosh, S. & Kitano, H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS One. 8(12), e83922 (2013).","journal-title":"PLoS One"},{"key":"76465_CR19","doi-asserted-by":"crossref","unstructured":"Win, S., Than, T. A. & Kaplowitz, N. The regulation of JNK Signaling pathways in Cell Death through the interplay with mitochondrial SAB and Upstream Post-translational effects. Int. J. Mol. Sci. 19(11). (2018).","DOI":"10.3390\/ijms19113657"},{"key":"76465_CR20","doi-asserted-by":"crossref","unstructured":"Teng, Y. H. et al. Autophagy protects from raddeanin A-induced apoptosis in SGC-7901 human gastric cancer cells. Evid. Based Complement Alternat. Med. 2016, 9406758 (2016).","DOI":"10.1155\/2016\/9406758"},{"issue":"12","key":"76465_CR21","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/pro.2374","volume":"22","author":"W Peti","year":"2013","unstructured":"Peti, W. & Page, R. Molecular basis of MAP kinase regulation. Protein Sci. 22(12), 1698\u20131710 (2013).","journal-title":"Protein Sci."},{"issue":"7","key":"76465_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40265-021-01514-0","volume":"81","author":"RA Elnair","year":"2021","unstructured":"Elnair, R. A. & Holstein, S. A. Evolution of treatment paradigms in newly diagnosed multiple myeloma. Drugs. 81(7), 825\u2013840 (2021).","journal-title":"Drugs"},{"key":"76465_CR23","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2147\/JHC.S413996","volume":"10","author":"Y Peng","year":"2023","unstructured":"Peng, Y. et al. An overview of traditional Chinese medicine in the treatment after Radical Resection of Hepatocellular Carcinoma. J. Hepatocell Carcinoma. 10, 2305\u20132321 (2023).","journal-title":"J. Hepatocell Carcinoma"},{"key":"76465_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.taap.2018.05.025","volume":"353","author":"B Ma","year":"2018","unstructured":"Ma, B. et al. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS\/JNK and NF-kappaB signal pathway. Toxicol. Appl. Pharmacol. 353, 87\u2013101 (2018).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"76465_CR25","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.18632\/aging.202574","volume":"13","author":"X Shen","year":"2021","unstructured":"Shen, X. et al. Raddeanin A inhibits proliferation, invasion, migration and promotes apoptosis of cervical cancer cells via regulating miR-224-3p\/Slit2\/Robo1 signaling pathway. Aging (Albany NY). 13(5), 7166\u20137179 (2021).","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"76465_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1590\/1519-6984.228437","volume":"81","author":"E Obeng","year":"2021","unstructured":"Obeng, E. Apoptosis (programmed cell death) and its signals - a review. Braz J. Biol. 81(4), 1133\u20131143 (2021).","journal-title":"Braz J. Biol."},{"issue":"4","key":"76465_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto, G. et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 8(4), 603\u2013619 (2016).","journal-title":"Aging (Albany NY)"},{"issue":"6367","key":"76465_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/356356a0","volume":"356","author":"MS Satoh","year":"1992","unstructured":"Satoh, M. S. & Lindahl, T. Role of poly(ADP-ribose) formation in DNA repair. Nature. 356(6367), 356\u2013358 (1992).","journal-title":"Nature"},{"issue":"6495","key":"76465_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/371346a0","volume":"371","author":"YA Lazebnik","year":"1994","unstructured":"Lazebnik, Y. A. et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371(6495), 346\u2013347 (1994).","journal-title":"Nature"},{"key":"76465_CR30","doi-asserted-by":"crossref","unstructured":"Cohen, G. M. Caspases: the executioners of apoptosis. Biochem J, 326 (Pt 1)(Pt 1): pp. 1\u201316. (1997).","DOI":"10.1042\/bj3260001"},{"issue":"5","key":"76465_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","volume":"81","author":"M Tewari","year":"1995","unstructured":"Tewari, M. et al. Yama\/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81(5), 801\u2013809 (1995).","journal-title":"Cell"},{"issue":"6535","key":"76465_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/376037a0","volume":"376","author":"DW Nicholson","year":"1995","unstructured":"Nicholson, D. W. et al. Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis. Nature. 376(6535), 37\u201343 (1995).","journal-title":"Nature"},{"key":"76465_CR33","doi-asserted-by":"crossref","unstructured":"Peruch, M. et al. Subcellular effectors of Cocaine Cardiotoxicity: all roads lead to Mitochondria-A systematic review of the literature. Int. J. Mol. Sci.. 24(19) (2023).","DOI":"10.3390\/ijms241914517"},{"issue":"1","key":"76465_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11(1), 102 (2020).","journal-title":"Nat. Commun."},{"issue":"3","key":"76465_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13258-022-01359-1","volume":"45","author":"C Lee","year":"2023","unstructured":"Lee, C., Park, S. H. & Yoon, S. K. Genetic mutations affecting mitochondrial function in cancer drug resistance. Genes Genomics. 45(3), 261\u2013270 (2023).","journal-title":"Genes Genomics"},{"key":"76465_CR36","doi-asserted-by":"crossref","unstructured":"Green, D. R., Galluzzi, L. & Kroemer, G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 333(6046), 1109\u201312 (2011).","DOI":"10.1126\/science.1201940"},{"key":"76465_CR37","doi-asserted-by":"publisher","first-page":"850771","DOI":"10.3389\/fvets.2022.850771","volume":"9","author":"M Wei","year":"2022","unstructured":"Wei, M. et al. Effect of fluoride on cytotoxicity involved in mitochondrial dysfunction: a review of mechanism. Front. Vet. Sci. 9, 850771 (2022).","journal-title":"Front. Vet. Sci."},{"key":"76465_CR38","doi-asserted-by":"crossref","unstructured":"Ghosh, P. et al. Mitochondria Targeting as an effective strategy for Cancer Therapy. Int. J. Mol. Sci., 21(9). (2020).","DOI":"10.3390\/ijms21093363"},{"issue":"3","key":"76465_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan, K., Werner, M. & Chandel, N. S. Mitochondrial metabolism as a target for Cancer Therapy. Cell. Metab. 32(3), 341\u2013352 (2020).","journal-title":"Cell. Metab."},{"issue":"6","key":"76465_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ceb.2009.09.004","volume":"21","author":"D Brenner","year":"2009","unstructured":"Brenner, D. & Mak, T. W. Mitochondrial cell death effectors. Curr. Opin. Cell. Biol. 21(6), 871\u2013877 (2009).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"76465_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-4020-6554-5_3","volume":"615","author":"A Chalah","year":"2008","unstructured":"Chalah, A. & Khosravi-Far, R. The mitochondrial death pathway. Adv. Exp. Med. Biol. 615, 25\u201345 (2008).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"76465_CR42","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbamcr.2010.10.017","volume":"1813","author":"J Lindsay","year":"2011","unstructured":"Lindsay, J., Esposti, M. D. & Gilmore, A. P. Bcl-2 proteins and mitochondria\u2013specificity in membrane targeting for death. Biochim. Biophys. Acta. 1813(4), 532\u2013539 (2011).","journal-title":"Biochim. Biophys. Acta"},{"issue":"20","key":"76465_CR43","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1073\/pnas.91.20.9238","volume":"91","author":"T Sato","year":"1994","unstructured":"Sato, T. et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. U S A. 91(20), 9238\u20139242 (1994).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"76465_CR44","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1182\/blood.V89.2.630","volume":"89","author":"P Zhou","year":"1997","unstructured":"Zhou, P. et al. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood. 89(2), 630\u2013643 (1997).","journal-title":"Blood"},{"issue":"3","key":"76465_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell, J. W. et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11(3), 191\u2013200 (2012).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"4","key":"76465_CR46","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/CIRCULATIONAHA.111.089243","volume":"125","author":"J Loscalzo","year":"2012","unstructured":"Loscalzo, J. Personalized cardiovascular medicine and drug development: time for a new paradigm. Circulation. 125(4), 638\u2013645 (2012).","journal-title":"Circulation"},{"issue":"7607","key":"76465_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/534314a","volume":"534","author":"N Nosengo","year":"2016","unstructured":"Nosengo, N. Can you teach old drugs new tricks? Nature. 534(7607), 314\u2013316 (2016).","journal-title":"Nature"},{"issue":"2","key":"76465_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales, C. et al. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci. 43(2), 136\u2013150 (2022).","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"76465_CR49","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s11011-021-00816-2","volume":"36","author":"ZK Qiu","year":"2021","unstructured":"Qiu, Z. K. et al. A network pharmacology study with molecular docking to investigate the possibility of licorice against posttraumatic stress disorder. Metab. Brain Dis. 36(7), 1763\u20131777 (2021).","journal-title":"Metab. Brain Dis."},{"key":"76465_CR50","doi-asserted-by":"crossref","unstructured":"Yu, X. et al. Hesperetin promotes diabetic wound healing by inhibiting ferroptosis through the activation of SIRT3. Phytother. Res. (2024).","DOI":"10.1002\/ptr.8121"},{"issue":"1","key":"76465_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40246-023-00544-x","volume":"17","author":"M Petrosino","year":"2023","unstructured":"Petrosino, M. et al. The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants. Hum. Genomics. 17(1), 95 (2023).","journal-title":"Hum. Genomics"},{"key":"76465_CR52","doi-asserted-by":"crossref","unstructured":"Martin-Vega, A. & Cobb, M. H. Navigating the ERK1\/2 MAPK Cascade. Biomolecules. 13(10) (2023).","DOI":"10.3390\/biom13101555"},{"issue":"2","key":"76465_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","volume":"344","author":"X Sui","year":"2014","unstructured":"Sui, X. et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 344(2), 174\u2013179 (2014).","journal-title":"Cancer Lett."},{"issue":"5","key":"76465_CR54","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/cas.14008","volume":"110","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma. Cancer Sci. 110(5), 1746\u20131759 (2019).","journal-title":"Cancer Sci."},{"key":"76465_CR55","doi-asserted-by":"publisher","first-page":"102137","DOI":"10.1016\/j.ctrv.2020.102137","volume":"92","author":"E Kun","year":"2021","unstructured":"Kun, E. et al. MEK inhibitor resistance mechanisms and recent developments in combination trials. Cancer Treat. Rev. 92, 102137 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"76465_CR56","doi-asserted-by":"crossref","unstructured":"Naz, I. et al. Anticancer potential of Raddeanin A, a natural triterpenoid isolated from Anemone Raddeana Regel. Molecules. 25(5) (2020).","DOI":"10.3390\/molecules25051035"},{"key":"76465_CR57","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.2147\/IJN.S420803","volume":"18","author":"K He","year":"2023","unstructured":"He, K. et al. A Pegylated Liposome loaded with raddeanin A for prostate Cancer therapy. Int. J. Nanomed. 18, 4007\u20134021 (2023).","journal-title":"Int. J. Nanomed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76465-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76465-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76465-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T10:03:02Z","timestamp":1732356182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76465-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76465"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76465-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29061"}}